<?xml version="1.0" encoding="UTF-8"?>
<ref id="R52">
 <label>52.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>O’Brien</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Furman</surname>
    <given-names>RR</given-names>
   </name>
   <name>
    <surname>Coutre</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Single-agent ibrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience</article-title>. 
  <source>
   <italic toggle="yes">Blood.</italic>
  </source>
  <year>2018</year>;
  <volume>131</volume>:
  <fpage>1910</fpage>–
  <lpage>1919</lpage>.
  <pub-id pub-id-type="pmid">29437592</pub-id>
 </mixed-citation>
</ref>
